Skip to content

Laparoscopic Adrenalectomy Versus Radiofrequency Ablation

Laparoscopic Adrenalectomy Versus Radiofrequency Ablation for Aldosterone-producing Adenoma: a Prospective Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02030587
Acronym
LARFA
Enrollment
36
Registered
2014-01-08
Start date
2013-01-31
Completion date
2017-12-31
Last updated
2017-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adrenocortical Adenoma, Conn Syndrome, Hyperaldosteronism

Keywords

Hyperaldosteronism, Adrenocortical adenoma, Adrenalectomy, Catheter ablation

Brief summary

This is a prospective randomized controlled study comparing laparoscopic adrenalectomy (LA) versus image-guided percutaneous radiofrequency ablation (RFA) in treating aldosterone-producing adenoma. The objectives of this study are to 1. compare the short-term outcomes of LA and RFA in treating aldosterone-producing adenoma. 2. compare the treatment success rates of LA and RFA during follow-up for primary aldosteronism.

Interventions

PROCEDURERadiofrequency Ablation

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Hypertensive individuals 2. Biochemically confirmed primary aldosteronism 3. Radiologically confirmed unilateral adrenal adenoma ≤3cm

Exclusion criteria

1. Bilateral adrenal disease 2. Multiple adrenal tumors 3. Other concomitant adrenal diseases 4. Potentially malignant adrenal tumors as shown on imaging 5. Uncorrected coagulopathy 6. Surgically unfit for general anaesthesia 7. Prior open abdominal surgery

Design outcomes

Primary

MeasureTime frame
Morbidity rate30-day
Resolution of hyperaldosteronism1 year

Secondary

MeasureTime frame
Mortality rate30 days
Blood loss24 hours
Analgesic requirement30 days
Time to resumption of activity30 days
Operative time24 hours
Blood pressure control1 year
Hospital stay30 days
Pain score7 days
Resolution of hypokalaemia1 year
Periprocedural hypertensive crisis24 hours

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026